Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least

Abbott Laboratories remains a "Buy," anticipating double-digit growth, despite near-term volatility and underwhelming 2026 ...
finance.biggo

[Abbott Laboratories Q3 2026 Earnings Call] Abbott to Spin Off $8.5 Billion Nutrition Unit as CEO Defends 'Position of Strength'

Abbott Laboratories will separate its nutrition business into an independent, publicly traded company via a tax-free spin-off by the end of 2027, ...

Billionaires and Trump Were Buying This Healthcare Stock

Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 ...

Abbott (ABT) Q3 2026 Earnings Call Transcript

Welcome to Abbott's third quarter 2026 earnings conference call. All participants will be able to listen only until the ...

What Can a Biological Age Test Actually Tell You?

Biological age tests claim to inform you about how your body is faring by telling you what age your blood test results most ...
abbott.mediaroom

Abbott's Cologuard Plus® receives CE Mark for colorectal cancer screening in Europe

Cologuard Plus is a noninvasive, stool-based DNA screening test designed to detect both colorectal cancer and advanced precancerous lesions In the pivotal BLUE-C study, Cologuard Plus ...
fxstreet

Australský dolar

02.10.2026 Hlavní faktor tržní volatility: Dnešní obchodní seanci dominovalo zveřejnění údajů z amerického trhu práce, které byly výrazně slabší, než se očekávalo. Americká ekonomika v září vytvořila ...
fxstreet

Zasedání Fedu

09.10.2026 Zlato (GOLD) dnes posiluje o téměř 1,2 %, přičemž na denním maximu si připisovalo až 1,5 %, když se pokouší vrátit k úrovni 4 200 USD za unci. Zdá se, že kov vytvořil lokální dno v rozmezí ...